Life after ibrutinib? A new unmet need in CLL.
Javier A Pinilla-IbarzJulio C ChavezPublished in: Blood (2015)
In this issue of Blood, Jain et al reported on the poor outcomes of patients with chronic lymphocytic leukemia (CLL) after the discontinuation of ibrutinib.